World Environment 2022: The World Environment Day is celebrated on June 5 of each year with the aim to mark the importance of…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Global Market
-
-
IndiaMerger / Acquisition
Dr. Reddy’s sells four Treatment Category Products to Torrent Pharma.
by adminby adminSummary : Torrent Pharmaceuticals, located in Ahmedabad, said on Thursday that it had agreed to buy four brands from Dr Reddy’s Laboratories…
-
Summary : The deal size is expected to be in the range of Rs 4,000-5,000 crore, sources close to the development .…
-
Global MarketIndiaLaunch
Nichino India Introduces Insecticide ‘Orchestra’(Benzpyrimoxan) to Control Brown Plant Hopper in Rice
by adminby adminSummary : Nichino India, a subsidiary of the Japanese agrochemical company Nihon Nohyaku Co, has launched Orchestra to combat the rice Brown…
-
CompaniesEuropeEurope Medicine Agency (EMA)Pfizer
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First ever Marketing Authorization by European Commission for both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
by adminby adminSummary : Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing…
-
EuropeEurope Medicine Agency (EMA)
Myovant Sciences Announces European Commission Approval for ORGOVYX® (Relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
by adminby adminSummary : ORGOVYX® is the first and only oral and rogend privation therapy for advanced hormone-sensitive prostate cancerin Europe Myovant expects to secure European…
-
Global MarketPatent LitigationPatents
FMC Corporation Wins Patent Infringement Case Against Udragon for Chlorantraniliprole
by adminby adminSummary : The Hangzhou Intermediate People’s Court in Zhejiang Province, China, awarded FMC a permanent injunction against Hangzhou Udragon Chemical Co., Ltd…
-
Global MarketRegulatoryU.S FDA
Sol-Gel Technologies and Galderma’s EPSOLAY® Scores US FDA Approval
by adminby adminSummary: EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of inflammatory lesions of rosacea and is patent…
-
CompaniesIndiaMerger / AcquisitionNovartis
Dr. Reddy’s will Pay Rs 463 Crore for Novartis’ Cardiovascular Drug Cidmus (Valsartan +Sacubitril)
by adminby adminSummary Dr Reddy’s Laboratories, an Indian generic pharmaceutical company, has agreed to pay $61 million to Novartis AG for the cardiovascular brand…
-
BrazilPatents
INPI Publishes an Update on the Terms of Patent Protection for Pharmaceutical and Non-Pharmaceutical Claims.
by adminby adminSummary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…